The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of the skin using dissolvable Doxorubicin-containing Microneedle arrays ...
The $14 million facility in New Hyde Park will focus on both breast and gynecological cancers, officials said.
The department’s expanded use of security video and images is part of a $12 million technology upgrade approved by the Anchorage Assembly this week.
Requesty says its tech tightens security and brings down the costs of accessing large language models. It raised $3 million.
StockStory.org on MSN
Why Array (ARRY) Stock Is Up Today
What Happened? Shares of solar tracking systems manufacturer Array (NASDAQ:ARRY) jumped 5% in the afternoon session after positive macro developments for the solar industry, including a pledge from ...
Northamptonshire Telegraph on MSN
State-of-the-art £1.5m pharmacy opens in Kettering town centre for prescriptions, consultations, vaccinations and perfume
A Northamptonshire pharmacy chain has opened a newly renovated £1.5m branch in the heart of Kettering town centre.
The Legion 9i’s IPS-LCD display is a great example of the breed with superb color accuracy, a color gamut that spans 100 percent of sRGB and 99 percent of DCI-P3, and a maximum brightness of 520 nits ...
The Company will provide an update on its novel Doxorubicin containing Microneedle Array (D-MNA) treatment to non-invasively treat basal cell carcinoma of the skin (BCC) and development of Teverelix, ...
ZHONGSHAN, China, Sept. 28, 2025 /PRNewswire/ — Connect intelligence globally, illuminate the future. The 33rd Guzhen Lighting Fair ( “China (Guzhen) International Lighting Fair”) will be grandly held ...
We worked with AI (ChatGPT and Claude mostly) to spec an AI server to meet research grade standards for a two person lab. Our goal is to do AI research such as tuning LLMs, implementing LoRA/RAG ...
The Scythe Mugen 6 Black Edition CPU cooler is an improvement in every way over the OG Mugen 6. An impressive feat to say the least.
Fewer than 5% of eligible patients worldwide receive cochlear implants todayHearing loss is the largest modifiable risk factor for dementia, linked to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results